Germany· DE-A57-b9509711d9321bfe

Lisdex- Aristo

A lisdexamfetamine product containing lisdexamfetamine dimesylate, registered in Germany by Aristo Pharma Gmbh (Art 57). The same ATC class is registered in 15 of our 19 countries.

ATC N06BA12

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lisdexamfetamine dimesylateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lisdexamfetamine is registered in 15 of 19 countries.

Countries holding a registration under ATC N06BA12 (lisdexamfetamine), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
8 of them publish a price we can compare per daily dose

Search lisdexamfetamine products by name

Lisdexamfetamine · ATC N06BA12

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lisdexamfetamine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lisdexamfetamine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Lisdexamfetamine Dimesylate
Manufacturer: Aristo Pharma Gmbh (Art 57)
Country: Germany (DE)
ATC code: N06BA12
ATC class: Lisdexamfetamine
Defined daily dose: 30 mg, O
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for lisdexamfetamine.

Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lisdexamfetamine against other medicines How interaction checks work

Lisdexamfetamine · interactions on record

217 records

51 severe
164 moderate
2 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
FenfluramineA08AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lisdexamfetamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lisdexamfetamine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Elvanse, Elvanse Erwachsene
Belgium · Elvanse
Czechia · Livizux
Denmark · Adixemin, Aduvanz
Estonia · Adixemin, Elvanse
Spain · Elvanse, Elvanse Adultos
Finland · Dexhility, Elvanse
France · Fobettin, Xurta
United Kingdom (Northern Ireland) · Elvanse, Elvanse Adult
Hungary · Livizux
Ireland · Lisdexamfetamine Dimesylate Rowex, Tyvense
Iceland · Amdex, Dexhility
Italy · Minalix
Lithuania · Adixemin
Luxembourg · Elvanse
Latvia · Adixemin, Lisdexamfetamine Zentiva
Malta · Lisdexamfetamin, Lisdexamfetamine Aristo Aristo
Netherlands · Elvanse, Lisdexamfetamine Aristo Aristo
Norway · Aduvanz, Balidax
Poland · Eldefab, Elvanse
Portugal · Dimesilato De Lisdexanfetamina Teva, Dimesilato De Lisdexanfetamina Zentiva
Romania · Lisdexamfetaminä Stada
Sweden · Balidax, Dexhility
Slovenia · Lisdeksamfetamin Aristo, Lisdeksamfetamin Aristo Aristo
Slovakia · Livizux

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bbb5df69-c976-4da3-b52c-0588b6493309
GET /v1/drugs/bbb5df69-c976-4da3-b52c-0588b6493309?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Lisdexamfetamine Dimesylate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about lisdexamfetamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console